Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
PaperCitations, authors & open-access status
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 404 citations, 2023 year and hybrid oa status.
404
Citations
2023
Year
hybrid
OA Status